Abstract. Detection of circulating tumor cells (CTCs) in the peripheral blood of metastatic cancer patients has clinical significance in earlier diagnosis of metastases. In this study, a novel cell microarray chip for accurate and rapid detection of tumor cells from human leukocytes was developed. The chip with 20,944 microchambers (105 µm diameter and 50 µm depth) was made from polystyrene, and the surface was rendered to hydrophilic by means of reactive-ion etching, which led to the formation of mono-layers of leukocytes on the microchambers. As the model of CTCs detection, we spiked human bronchioalveolar carcinoma (H1650) cells into human T lymphoblastoid leukemia (CEM) cells suspension and detected H1650 cells using the chip. A CEM suspension contained with H1650 cells was dispersed on the chip surface, followed by 10 min standing to allow the cells to settle down into the microchambers. About 30 CEM cells were accommodated in each microchamber, over 600,000 CEM cells in total being on a chip. We could detect 1 H1650 cell per 10 6 CEM cells on the microarray by staining with fluorescence-conjugated antibody (Anti-Cytokeratin) and cell membrane marker (DiD). Thus, this cell microarray chip has highly potential to be a novel tool of accurate and rapid detection of CTCs.
Introduction
In patients with metastatic cancer, there is growing evidence that the presence of circulating tumor cells (CTCs) in the blood may be an important indicator of the potential for prognosis in metastatic cancer. However, it is estimated that CTCs in the peripheral blood can occur at a frequency of approximately 1 CTC per 10 5 -10 7 peripheral blood mononuclear cells in metastatic cancer patients 1 . Although some techniques for CTCs detection, PCR 2 and flow cytometry 3 , are developed, they especially have a problem in sensitivity. Recently CTC separation methods, have been developed, capture cells with specific cell surface markers such as EpCAM by using magnetic beads or microstructures coated with a monoclonal antibody. CellSearch system (VeridexTM, Warren, PA), a commercialized semi-automated technology, enriches whole blood for CTCs by adding ferrofluids coated with EpCAM-specific antibodies 4 . In addition, some microfluidic devices have been developed to detect CTCs from whole blood, and the devices enable easy and efficient separation of CTCs 5 .
Although these EpCAM-based methods can detect low frequency of only EpCAM-positive CTCs from whole blood, they cannot achieve reproducible recovery of CTCs from all types of tumor. In previous our study, we already developed a cell microarray chip for rapid and highly sensitive detection of antigen-specific single B-cells 6 and malaria-infected erythrocytes 7 . Here, we have developed a novel high-throughput screening and analysis system for CTCs allowing high sensitivity in a short time using a cell microarray chip made from polystyrene with over 20,000 individually addressable microchambers. Our cell microarray chip has been improved to allow the dispersion of a leukocytes suspension contained with cancer cells into the microchambers regularly, with the formation of a monolayer, and analysis with a microarray scanner for detection of the presence of cancer cells in leukocytes. The potential of a cell microarray chip system for the early diagnosis of metastases was shown, it allowing accurate detection of CTCs in a short time.
Experimental

Construction of a cell microarray chip
The cell microarray chip with 20,944 microchambers (105 µm diameter, 50 µm depth, and 300 µm pitch) was made from polystyrene by the Lithographie Galvanoformung Abformung (LIGA) process by Starlight Co. Ltd. (Osaka, Japan) ( Figure 1 ) 6 . The polystyrene microarray chip was fabricated with a nickel mold by injection molding. The microarray chip has 112 (14 x 8) clusters of 187 microchambers, respectively. There are block numbers on the clusters for easy confirmation of cancer cells in leukocytes. Each microchamber comprises a frustum in shape. The cell microarray chip surface was rendered hydrophilic by means of reactive ion-etching (RIE) treatment using a SAMCO RIE system (SAMCO, Inc., Tokyo, Japan) for achieving leukocytes confinement in the microchambers. RIE exposure time controlled cell adhesion on the polystyrene chip surface. The effect of RIE exposure on the microarray chip surface was examined by measuring the contact angle of water on the chip surface using a contact-angle meter (Kyowa Interface Science Co., Ltd., Saitama, Japan) 6 . 
Detection of carcinoma cells on a cell microarray chip
For tightly confinement of leukocytes in the microchambers, T lymphoblastoid leukemia (CEM) cells in RPMI 1640 medium (pH 7.4) with Penicilline-Streptomycin, Fungizone and Fetal Bovine Serum (FBS) at cell concentration of 2.5 x10 6 cells/ml, 5.0 x10 6 cells/ml, 7.5 x10 6 cells/ml, or 1.0x10 7 cells/ml were dispersed on the cell microarray chip, followed by 15 min standing to allow the CEM cells to settle down enter into the microchambers under gravitational force. Microchambers were examined by light microscopy. suspension was dispersed manually on the cell microarray chip using a pipette, followed by 15 min standing to allow the CEM cells to settle down into the microchambers under gravitational force, and then staining with Anti-Cytokeratin and DiD. Then excess cells on the chip surface were removed by gentle washing with RPMI 1640 medium. The microarray chip was scanned with a confocal laserbased fluorescence microarray scanner, CRBIO IIe (Hitachi Software Engineering Co., Ltd., Tokyo, Japan). The system exhibits resolution of up to 10 µm and sensitivity of < 0.1 fluorescent molecule/µm 2 , and is fitted with filters with emission wavelengths of 535 and 585 nm. The fluorescence intensity of individual CEM and H1650 cells was determined with DNASIS Array version 2.1 software (Hitachi Software Enginnering Co., Ltd), and the both cells that exhibited fluorescence intensities of ten times higher that of background were taken to be fluorescence-positive ones.
Results and Discussions
Dispersion of leukocytes on a cell microarray chip
To achieve the confinement of leukocytes in microchambers, the hydrophilicity on the microarray chip surface was optimized by means of RIE exposure 6, 7 . It was observed that increase in the exposure time of RIE increases the hydrophilicity of the chip surface, which is inversely proportional to the decrease in the contact angle of the chip surface 6 . And also it was observed that the polystyrene microarray chip maintained a hydrophilicity character without alteration for at least one week. Eightyseconds exposure gave appropriate hydrophilicity on the chip surface, and CEM cells could settle in each microchamber (data not shown). For the formation of a mono-layer of CEM cells on the bottom surface of the microchambers after washing, the cell microarray chip was designed to have 105 µm diameter microchambers of 50 µm in depth and a cone-shaped frustum. Because in previous our study, we already developed a cell microarray chip for the formation of monolayers of erythrocytes 7 . The CEM cells suspension is dropped on to the chip using a pipette, and then the CEM cells settle down under gravitational force and adhere to the chip surface with the formation of multi-layer. After washing of the chip surface using a pipette, CEM cells adhered to the bottom surface of each microchamber as a monolayer formation (Figure 2) . It was observed that the number of CEM cells confined in the microchambers depended on the CEM cells concentration on the cell microarray chip, and CEM cells were tightly confined with over 7.5 x10 6 cells/ml. The number of confined CEM cells was determined to be 29 ± 2 per microchamber with over 7.5 x10 6 cells/ml. So, over 600,000 CEM cells are dispersed as a monolayer in the microchambers on a microarray chip. This cell microarray chip system has highly potential to be high-throughput screening and analysis of many kind of cells without any complicated equipments. microarray chip and then scanning images were obtained ( Figure 3 ). Cytokeratin-positive cells were not observed among CEM cells as used a negative control. Cytokeratin-positive cells were observed in the microchambers with 0.01%, 0.001%, and 0.0001% H1650 cells, the total numbers of fluorescence-positive erythrocytes being as 99±2.6, 9.7±0.3 and 1.0±0.0 (n=3) in 184 microchamber areas, as determined with DNASIS Array software, respectively. The percentage of cancer cells was determined using the following formula: [(number of Cytokeratin-positive H1650/1,000,000 erythrocytes) x 100]. The percentages of H1650 were calculated to be 0.0099%, 0.00097% and 0.0001%, respectively. These calculated cancer cells ratios were well consistent with the practical ratios. Our cell microarray chip exhibits sensitivity (1 H1650 cell per 10 6 CEM cells) as high as that of reported microchip devices for CTCs detection, and only 15 min is required for the detection carcinoma cells without any complicated technical handling. Additionally, with this cell microarray chip, high accuracy was obtained because only cancer cells among mono-layered leukocytes were targeted on and detected with a confocal fluorescence laser scanning system. Therefore, this cell microarray chip has highly potential to be a novel device of accurate and rapid detection of CTCs and early diagnosis system of metastatic cancer. 
